Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 8029728, 13 pages
https://doi.org/10.1155/2017/8029728
Research Article

Basal and Activated Calcium Sensitization Mediated by RhoA/Rho Kinase Pathway in Rats with Genetic and Salt Hypertension

Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic

Correspondence should be addressed to Michal Behuliak; zc.sac.ugf@kailuheb.lahcim

Received 29 August 2016; Revised 27 November 2016; Accepted 15 December 2016; Published 19 January 2017

Academic Editor: Jun Ren

Copyright © 2017 Michal Behuliak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. P. Somlyo and A. V. Somlyo, “Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II,” Journal of Physiology, vol. 522, no. 2, pp. 177–185, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Wirth, “Rho kinase and hypertension,” Biochimica et Biophysica Acta, vol. 1802, no. 12, pp. 1276–1284, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Shi and L. Wei, “Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil,” Journal of Cardiovascular Pharmacology, vol. 62, no. 4, pp. 341–354, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Loirand and P. Pacaud, “Involvement of Rho GTPases and their regulators in the pathogenesis of hypertension,” Small GTPases, vol. 5, no. 4, Article ID e983866, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Shimokawa, S. Sunamura, and K. Satoh, “RhoA/Rho-Kinase in the cardiovascular system,” Circulation Research, vol. 118, no. 2, pp. 352–366, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Narita, T. Nagao, H. Yabana, and I. Yamaguchi, “Hypotensive and diuretic actions of diltiazem in spontaneously hypertensive and Wistar Kyoto Rats,” Journal of Pharmacology and Experimental Therapeutics, vol. 227, no. 2, pp. 472–477, 1983. View at Google Scholar · View at Scopus
  7. Y. Takata and J. S. Hutchinson, “Exaggerated hypotensive responses to calcium antagonists in spontaneously hypertensive rats,” Clinical and Experimental Hypertension, Part A: Theory and Practice, vol. 5, no. 6, pp. 827–847, 1983. View at Publisher · View at Google Scholar · View at Scopus
  8. J. N. Sharma, P. G. Fernandez, I. Laher, and C. R. Triggle, “Differential sensitivity of Dahl salt-sensitive and Dahl salt-resistant rats the hypotensive action of acute nifedipine administration,” Canadian Journal of Physiology and Pharmacology, vol. 62, no. 2, pp. 241–243, 1984. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Kuneš, S. Hojná, M. Kadlecová et al., “Altered balance of vasoactive systems in experimental hypertension: the role of relative NO deficiency,” Physiological Research, vol. 53, S1, pp. S23–S34, 2004. View at Google Scholar · View at Scopus
  10. M. Uehata, T. Ishizaki, H. Satoh et al., “Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension,” Nature, vol. 389, no. 6654, pp. 990–994, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Mukai, H. Shimokawa, T. Matoba et al., “Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension,” The FASEB Journal, vol. 15, no. 6, pp. 1062–1064, 2001. View at Google Scholar · View at Scopus
  12. M. Löhn, K. Steioff, M. Bleich, A. E. Busch, and Y. Ivashchenko, “Inhibition of Rho-kinase stimulates nitric oxide-independent vasorelaxation,” European Journal of Pharmacology, vol. 507, no. 1–3, pp. 179–186, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Behuliak, M. Pintérová, M. Bencze et al., “Ca2+ sensitization and Ca2+ entry in the control of blood pressure and adrenergic vasoconstriction in conscious Wistar-Kyoto and spontaneously hypertensive rats,” Journal of Hypertension, vol. 31, no. 10, pp. 2025–2035, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. J. S. Dhaliwal, D. B. Casey, A. J. Greco et al., “Rho kinase and Ca2+ entry mediate increased pulmonary and systemic vascular resistance in L-NAME-treated rats,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 293, no. 5, pp. L1306–L1313, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. D. B. Casey, A. M. Badejo, J. S. Dhaliwal et al., “Analysis of responses to the Rho-kinase inhibitor Y-27632 in the pulmonary and systemic vascular bed of the rat,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 299, no. 1, pp. H184–H192, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Shimokawa and K. Satoh, “2015 ATVB plenary lecture: translational research on Rho-kinase in cardiovascular medicine,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 35, no. 8, pp. 1756–1769, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Masumoto, Y. Hirooka, H. Shimokawa, K. Hironaga, S. Setoguchi, and A. Takeshita, “Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans,” Hypertension, vol. 38, no. 6, pp. 1307–1310, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. C. J. Smith, L. Santhanam, and L. M. Alexander, “Rho-Kinase activity and cutaneous vasoconstriction is upregulated in essential hypertensive humans,” Microvascular Research, vol. 87, pp. 58–64, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Komers, T. T. Oyama, D. R. Beard et al., “Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure,” Kidney International, vol. 79, no. 4, pp. 432–442, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Komers, “Rho kinase inhibition in diabetic kidney disease,” British Journal of Clinical Pharmacology, vol. 76, no. 4, pp. 551–559, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Nishikimi and H. Matsuoka, “Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effect of Rho-kinase inhibitor in hypertensive glomerulosclerosis,” Journal of Pharmacological Sciences, vol. 100, no. 1, pp. 22–28, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. O. Pecháňová, Z. Dobešová, J. Čejka, J. Kuneš, and J. Zicha, “Vasoactive systems in L-NAME hypertension: the role of inducible nitric oxide synthase,” Journal of Hypertension, vol. 22, no. 1, pp. 167–173, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Pintérová, P. Karen, J. Kuneš, and J. Zicha, “Role of nifedipine-sensitive sympathetic vasoconstriction in maintenance of high blood pressure in spontaneously hypertensive rats: effect of Gi-protein inactivation by pertussis toxin,” Journal of Hypertension, vol. 28, no. 5, pp. 969–978, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Behuliak, M. Pintérová, J. Kune, and J. Zicha, “Vasodilator efficiency of endogenous prostanoids, Ca2+-activated K+ channels and nitric oxide in rats with spontaneous, salt-dependent or NO-deficient hypertension,” Hypertension Research, vol. 34, no. 8, pp. 968–975, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Zicha, Z. Dobešová, M. Behuliak, J. Kuneš, and I. Vaněčková, “Preventive dietary potassium supplementation in young salt-sensitive Dahl rats attenuates development of salt hypertension by decreasing sympathetic vasoconstriction,” Acta Physiologica, vol. 202, no. 1, pp. 29–38, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Vaněčková, Z. Dobešová, J. Kuneš, and J. Zicha, “The effects of repeated delivery of angiotensin II AT1 receptor antisense on distinct vasoactive systems in Ren-2 transgenic rats: young vs. adult animals,” Hypertension Research, vol. 35, no. 7, pp. 761–768, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. V. Sauzeau, H. Le Jeune, C. Cario-Toumaniantz et al., “Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle,” Journal of Biological Chemistry, vol. 275, no. 28, pp. 21722–91729, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Zicha, M. Behuliak, M. Pintérová, M. Bencze, J. Kuneš, and I. Vaněčková, “The interaction of calcium entry and calcium sensitization in the control of vascular tone and blood pressure of normotensive and hypertensive rats,” Physiological Research, vol. 63, supplement 1, pp. S19–S27, 2014. View at Google Scholar · View at Scopus
  29. S. M. Alvarez, A. S. Miner, B. M. Browne, and P. H. Ratz, “Failure of Bay K 8644 to induce RhoA kinase-dependent calcium sensitization in rabbit blood vessels,” British Journal of Pharmacology, vol. 160, no. 6, pp. 1326–1337, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Behuliak, A. Vavřínová, M. Bencze et al., “Ontogenetic changes in contribution of calcium sensitization and calciumentry to blood pressure maintenance of Wistar-Kyoto and spontaneously hypertensive rats,” Journal of Hypertension, vol. 33, no. 12, pp. 2443–2454, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. Dobešová, J. Kuneš, and J. Zicha, “The altered balance between sympathetic nervous system and nitric oxide in salt hypertensive Dahl rats: Ontogenetic and F2 hybrid studies,” Journal of Hypertension, vol. 20, no. 5, pp. 945–955, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Paulis, S. Líšková, M. Pintérová, Z. Dobešová, J. Kuneš, and J. Zicha, “Nifedipine-sensitive noradrenergic vasoconstriction is enhanced in spontaneously hypertensive rats: the influence of chronic captopril treatment,” Acta Physiologica, vol. 191, no. 4, pp. 255–266, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. M. T. Nelson, N. B. Standen, J. E. Brayden, and J. F. Worley III, “Noradrenaline contracts arteries by activating voltage-dependent calcium channels,” Nature, vol. 336, no. 6197, pp. 382–385, 1988. View at Publisher · View at Google Scholar · View at Scopus
  34. M.-H. Tsai and M. J. Jiang, “Rho-kinase-mediated regulation of receptor-agonist-stimulated smooth muscle contraction,” Pflügers Archiv, vol. 453, no. 2, pp. 223–232, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. D. F. Su, C. Cerutti, C. Barrès, M. Vincent, and J. Sassard, “Blood pressure and baroreflex sensitivity in conscious hypertensive rats of Lyon strain,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 251, no. 6, pp. H1111–H1117, 1986. View at Google Scholar · View at Scopus
  36. J. Nedvidek and J. Zicha, “Age-dependent changes of baroreflex efficiency in Dahl rats: effects of high salt intake,” Physiological Research, vol. 42, no. 3, pp. 209–212, 1993. View at Google Scholar · View at Scopus
  37. A. Borgonio, S. Pummer, K. Witte, and B. Lemmer, “Reduced baroreflex sensitivity and blunted endogenous nitric oxide synthesis precede the development of hypertension in TGR(mREN2)27 rats,” Chronobiology International, vol. 18, no. 2, pp. 215–226, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. J. F. R. Paton, H. Waki, A. P. L. Abdala, J. Dickinson, and S. Kasparov, “Vascular-brain signaling in hypertension: role of angiotensin II and nitric oxide,” Current Hypertension Reports, vol. 9, no. 3, pp. 242–247, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Brunová, M. Bencze, M. Behuliak, and J. Zicha, “Acute and chronic role of nitric oxide, renin-angiotensin system and sympathetic nervous system in the modulation of calcium sensitization in wistar rats,” Physiological Research, vol. 64, no. 4, pp. 447–457, 2015. View at Google Scholar · View at Scopus
  40. J. Zicha, M. Behuliak, and I. Vaneckova, “Decreased Rho-kinase-based calcium sensitization in hypertensive Ren-2 transgenic rats (TGR),” Journal of Hypertension, vol. 34, no. 1, article e58, 2016. View at Publisher · View at Google Scholar
  41. S. Wolfrum, A. Dendorfer, Y. Rikitake et al., “Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 10, pp. 1842–1847, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Sakurada, N. Takuwa, N. Sugimoto et al., “Ca2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction,” Circulation Research, vol. 93, no. 6, pp. 548–556, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Fernández-Tenorio, C. Porras-González, A. Castellano, A. Del Valle-Rodríguez, J. López-Barneo, and J. Ureña, “Metabotropic regulation of RhoA/Rho-associated kinase by L-type Ca2+ channels: new mechanism for depolarization-evoked mammalian arterial contraction,” Circulation Research, vol. 108, no. 11, pp. 1348–1357, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Hata, J. Soga, T. Hidaka et al., “Calcium channel blocker and Rho-associated kinase activity in patients with hypertension,” Journal of Hypertension, vol. 29, no. 2, pp. 373–379, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Kanda, S. Wakino, K. Hayashi, K. Homma, Y. Ozawa, and T. Saruta, “Effect of fasudil on Rho-kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats,” Kidney International, vol. 64, no. 6, pp. 2009–2019, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Ishikawa, T. Nishikimi, K. Akimoto, K. Ishimura, H. Ono, and H. Matsuoka, “Long-term administration of Rho-kinase inhibitor ameliorates renal damage in malignant hypertensive rats,” Hypertension, vol. 47, no. 6, pp. 1075–1083, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Nishikimi, S. Koshikawa, Y. Ishikawa et al., “Inhibition of Rho-kinase attenuates nephrosclerosis and improves survival in salt-loaded spontaneously hypertensive stroke-prone rats,” Journal of Hypertension, vol. 25, no. 5, pp. 1053–1063, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Koshikawa, T. Nishikimi, C. Inaba, K. Akimoto, and H. Matsuoka, “Fasudil, a Rho-kinase inhibitor, reverses L-NAME exacerbated severe nephrosclerosis in spontaneously hypertensive rats,” Journal of Hypertension, vol. 26, no. 9, pp. 1837–1848, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. N. Kobayashi, S. Horinaka, S.-I. Mita et al., “Critical role of Rho-kinase pathway for cardiac performance and remodeling in failing rat hearts,” Cardiovascular Research, vol. 55, no. 4, pp. 757–767, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Nishikimi, K. Akimoto, X. Wang et al., “Fasudil, a Rho-kinase inhibitor, attenuates glomerulosclerosis in Dahl salt-sensitive rats,” Journal of Hypertension, vol. 22, no. 9, pp. 1787–1796, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. S.-I. Mita, N. Kobayashi, K. Yoshida, S. Nakano, and H. Matsuoka, “Cardioprotective mechanisms of Rho-kinase inhibition associated with eNOS and oxidative stress-LOX-1 pathway in Dahl salt-sensitive hypertensive rats,” Journal of Hypertension, vol. 23, no. 1, pp. 87–96, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Fukui, Y. Fukumoto, J. Suzuki et al., “Long-term inhibition of Rho-kinase ameliorates diastolic heart failure in hypertensive rats,” Journal of Cardiovascular Pharmacology, vol. 51, no. 3, pp. 317–326, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Kazda, B. Garthoff, J. Dycka, and J. Iwai, “Prevention of malignant hypertension in salt loaded “S” Dahl rats with the calcium antagonist nifedipine,” Clinical and Experimental Hypertension A, vol. 4, no. 7, pp. 1231–1241, 1982. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Kazda, B. Garthoff, and G. Luckhaus, “Calcium and malignant hypertension in animal experiment: effects of experimental manipulation of calcium influx,” American Journal of Nephrology, vol. 6, supplement 1, pp. 145–150, 1986. View at Publisher · View at Google Scholar · View at Scopus
  55. J. A. McCaughran Jr. and C. J. Juno, “Calcium channel blockade with verapamil. Effects on blood pressure, renal, and myocardial adrenergic, cholinergic, and calcium channel receptors in inbred Dahl hypertension-sensitive (S/JR) and hypertension-resitant (R/JR) rats,” American Journal of Hypertension, vol. 1, no. 3, pp. 255S–262S, 1988. View at Google Scholar · View at Scopus
  56. C. Porras-González, P. González-Rodríguez, E. Calderón-Sánchez, J. López-Barneo, and J. Ureña, “Low-dose combination of Rho kinase and L-type Ca2+ channel antagonists for selective inhibition of depolarization-induced sustained arterial contraction,” European Journal of Pharmacology, vol. 732, no. 1, pp. 130–138, 2014. View at Publisher · View at Google Scholar · View at Scopus